Hypoglycemic APIs are a class of compounds designed to control and treat diabetes, a chronic metabolic disease characterized by hyperglycemia. Protheragen provides a full range of anti-diabetic APIs, covering biguanides, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibition agents and glucagon-like peptide 1 (GLP-1) receptor agonists, etc. These compounds work through different mechanisms to regulate blood sugar levels and improve insulin sensitivity.

• Listing ID: 53564

1. Check all listings by this user
2. Add to favourites
3. Report abuse

Contact details

Contact this listing owner

Your Name*

Your E-mail Address*

Your Phone Number

Your Message*

Submit